Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy.

Trial Profile

Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2011

At a glance

  • Drugs Esomeprazole; Rebamipide
  • Indications NSAID-induced gastric damage
  • Focus Pharmacodynamics
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 10 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 30 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top